Singapore Stock Market News

iX Biopharma - All in the delivery

StockFanatic
Publish date: Tue, 25 Aug 2015, 12:40 PM
StockFanatic
0 10,453
Welcome to Stockfanatic Singapore stock market and regional market news. This is a platform to share Singapore stock market and regional news to investors / man in the street. Investors can also look forward to analyst reports and brokers recommendations. Stockfanatic's Singapore stock market and regional news blog, home of investors one stop news station.

iX Biopharma is a specialty pharmaceutical company. The value of the company is in its patented WaferiX drug-delivery technology. iX currently has a portfolio of three products (all undergoing clinical development). Management projects commercialisation of its blockbuster product Wafermine in early-2018.

Short- to medium-term milestones in the eyes of management include regulatory approvals for the group‟s products while longer-term catalysts include large out-licensing contract wins (which is typical in this industry) and possible takeover offers.
Read more »
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment